Theralase Technologies Inc. V.TLT

New Press Release - Theralase(R) Successfully Destroys Lung Cancer

TORONTO, ON / ACCESSWIRE / June 6, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and/or radiation activated small molecules for the safe and...read article.

[Lesalpes29]

Let management secure the money needed for more than one year and the show will really begin! Have a good AGM day!

[enriquesuave]

This is going to be huge!  "Theralase® has demonstrated that all animals treated with x-ray activated Rutherrin® are currently alive; unfortunately, this is not the case for mice that received x-ray treatment only. In addition, the mice treated with x-ray activated Rutherrin® have demonstrated up to a 4-fold slower tumour progression, based on the Magnetic Resonance

[menoalittle]

Excellent news! (And a darn good reason to see it push into the 20's today.)

[Oden6570]

Perhaps this issue will be resolved sooner than we may have thought.  Pharma will want a piece of this technology and Theralase has so much upside. 

[made2last]

Hi all; HAPPY MICE, SHAREHOLDERS. Hopefully, humans will be getting well too! Theralase® has demonstrated that all animals treated with x-ray activated Rutherrin® are currently alive; unfortunately, this is not the case for mice that received x-ray treatment only. Thanks; made2last  

[anabelsi]

Aww, poor mice :( But oh man, at this point, if we get any positive financial news, the SP is going to explode - how the hell are institutions watching all of this and not getting in yet!?

[skys1]

anabelsi, The reason most financial institutions have to just sit by and not get involved in TLT is because usually their prospectous precludes them from trading on the Venture. Unfortunately, until we can move up to a more senior exchange, we have to live with it.

[Oilminerdeluxe]

Yes!! Nice. Money, please come our way. "This research may expand to include: pancreatic cancer, prostate cancer, kidney cancer and colorectal cancer, based on capitalization. Following successful completion of Phase Ia, a Phase Ib study will be commenced to determine patient efficacy, using x-ray activated Rutherrin®. Pending the successful completion of the Phase Ia/Ib clinical study

[StevenBirch]

I don't know how much more good news we can take.

[riverrrow]

It's great to see that xray activation works and puts all cancers into play for treatment.

[Oilminerdeluxe]

2 good releases within days of each other, Roger has a lot to talk about on the CC. If he chooses to. Questions afterwards will be plenty. Hope he stays to answer them. Exciting stuff.  Find a dance partner!

[tdon1229]

If you didn't presubmit your questions, don't expect answers.